Clinical trial
LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study
NCT04732728 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 5, 2021
- Completion date
- May 18, 2023
- Enrollment
- 727 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, cryptogenic stroke, syncope